ESC 365 - Is FDG PET for viability testing still viable?

Open Access

Is FDG PET for viability testing still viable?

Session: PET/CT applications in viability detection, sarcoidosis and vasculitis

Topic: Hybrid and Fusion Imaging

Speaker: Doctor R. Beanlands (Ottawa, CA)

Event: ICNC-CT 2021

Congress Presentation

About the speaker

Doctor Rob Beanlands

University of Ottawa Heart Institute, Ottawa (Canada)

4 presentations

0 follower

3 more presentations in this session

PET/CT imaging large vessel vasculitis and complications.

Speaker: Professor O. Gheysens (Brussels, BE)

PET/CT imaging in cardiac sarcoidosis: diagnosis and therapy monitoring.

Speaker: Doctor E. Miller (Boston, US)

PET/CT applications in viability detection, sarcoidosis and vasculitis - discussion.

Access the full session

PET/CT applications in viability detection, sarcoidosis and vasculitis

Speakers: Doctor R. Beanlands, Professor O. Gheysens, Doctor E. Miller

About the event

ICNC-CT 2021

9 May - 11 May 2021

Sessions Presentations

Congress

Related content

ESC Premium Access

Management of endocarditis: state of the art

28 August 2021

ESC Premium Access

TAVI challenges: antithrombotic management after TAVI and prevention of valve thrombosis and HALT.

28 August 2021

ESC Premium Access

Essential update on cardiac magnetic resonance: 10 'must' indications for best practices.

28 August 2021

ESC 365 is supported by